Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
AOD 9604 does not share this risk profile
Clinical trials have shown significant reductions in baseline body weight over extended treatment durations, particularly when dosing is escalated gradually under medical supervision
This was reflected in their EDE-Q scores which reduced by 3.5 and 0.7 points for P2 and P5 respectively
Sudden chills, fever, and shaking have led to hospitalization for possible blood infection in documented cases
US$ 22.37
-1775582746855.png&w=3840&q=75)
US$ 22.86
US$ 24.57
US$ 21.35
.jpg)
US$ 21.86
